Get started
Award

209057

Funded outputs count: 35
Funder award ID: 209057
OpenAlex ID: G6959079387
Circulating Inflammatory Markers and Mammographic Density Phenotypes: a Mendelian Randomization Analysis
2026 · Austin Hammermeister Suger, Tabitha A. Harrison, et al. · medRxiv
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
2026 · Billaud, Amandine, Figlioli, Gisella, et al. · Apollo (University of Cambridge)
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study
2026 · Jason L. Vassy, Anna M. Dornisch, et al. · Nature Cancer · 8
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
2025 · Amandine Billaud, Gisella Figlioli, et al. · The Breast · 2
PDF
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
2025 · Maria Zanti, Denise G. O’Mahony, et al. · Nature Communications · 11
PDF
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics
2024 · Trishna A. Desai, Åsa K. Hedman, et al. · EBioMedicine · 27
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2024 · Clarke, C.L., Anton-Culver, H., et al. · Kölner Universitäts PublikationsServer (Universität zu Köln)
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2024 · Koutros, S., Janni, W., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
2024 · Manoukian, S., Ramachandran, D., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Unravelling the Role of Iroquois Homeobox 4 and its Interplay with Androgen Receptor in Prostate Cancer
2023 · Jyotsna Batra, Janaththani Panchadsaram, et al. · Research Square · 1
PDF
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
2023 · Maria Zanti, Denise G. O'Mahony, et al. · Human Mutation · 6
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
2023 · Kote-Jarai, Z., The PRACTICAL Consortium, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study
2023 · Chaoran Ma, Xiaoyu Wang, et al. · Cancer Epidemiology Biomarkers & Prevention · 3
PDF
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
2023 · Hagai Levi, Shai Carmi, et al. · Journal of Medical Genetics · 4
PDF
Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
2023 · Anna Morra, Maartje A. C. Schreurs, et al. · Cancer Medicine · 11
PDF
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
2023 · Gisella Figlioli, Amandine Billaud, et al. · Cancers · 1
PDF
Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions
2023 · Sara Lindström, Lu Wang, et al. · JNCI Journal of the National Cancer Institute · 31
PDF
The impact of coding germline variants on contralateral breast cancer risk and survival
2023 · Anna Morra, Nasim Mavaddat, et al. · The American Journal of Human Genetics · 26
PDF
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
2023 · Gisella Figlioli, Amandine Billaud, et al. · European Journal of Human Genetics · 15
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023 · Josephine M.N. Lopes Cardozo, Irene L. Andrulis, et al. · Journal of Clinical Oncology · 29
PDF
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2022 · Suzanne C Dixon-Suen, Sarah J Lewis, et al. · British Journal of Sports Medicine · 88
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
2022 · Isabelle Grootes, Renske Keeman, et al. · European Journal of Cancer · 20
PDF
Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study
2022 · Fernanda Morales-Berstein, Daniel L McCartney, et al. · eLife · 86
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
2022 · Nasim Mavaddat, Leila Dorling, et al. · JAMA Oncology · 172
PDF
Rare germline copy number variants (CNVs) and breast cancer risk
2022 · Joe Dennis, Jonathan P. Tyrer, et al. · Communications Biology · 15
PDF
Year
Topic